Clinical Trial NCT06593938

Trial

Chengdu Suncadia Medicine – HRS-5965-301 (NCT06593938)

Clinical trial ID

NCT06593938

Drug name

HRS-5965

Company:

Chengdu Suncadia Medicine Co., Ltd

Drug trade name

Clinicaltrials.gov

Learn more

Phase of study

3

Current status

Active, not recruiting

Start

10/2024

Substance

HRS‑5965 capsules oral vs. eculizumab injection

Research question

Is oral HRS‑5965 as effective and safe compared to eculizumab injection over a 24‑week period in adult PNH patients naive to complement inhibitor therapy?

Delivery method of drug

Frequency

Daily

Clinical trial locations

China